Irreversible activation of CrGluClα by ivermectin. by Isabel Cornejo (634494)

“…<p>A. Current trace obtained at 60 mV during bath application of 50 µM glutamate and then to ivermectin at concentrations going from 1 to 3000 nM during the times shown in the boxes. …”

Map of study area. by Erin Conlisk (163376)

Phenotypes and Mg contents of banana (<i>Musa acuminata</i>) leaves under long-term MD. by Baolin Kan (12936933)

DataSheet_1_Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin.docx by Yingying Wang (124944)

Thin and thick slice perfusion maps. by Edwin Bennink (568194)

Molluscicidal activity and physiological toxicity of quaternary benzo[c]phenanthridine alkaloids (QBAs) from <i>Macleaya cordata</i> fruits on <i>Oncomelania hupensis</i> by Wenshan Ke (7490798)

“…GST, CarE, AKP, and ACP activity in the liver of snails treated with LC₅₀ QBAs for 120 h decreased by 62.3%, 78.1%, 59.2%, and 68.6%, respectively. …”

Image_5_Effects of tree species identity on soil microbial communities in Juglans nigra and Quercus rubra plantations.TIFF by Juan P. Frene (12227753)

Table5_Characterization of exogenous αSN response genes and their relation to Parkinson’s disease using network analyses.XLSX by Zahra Nayeri (8837267)

“…Inhibitors of the “TNF-α signaling via NF-κB” pathway may, therefore, decrease the activity level of this pathway and thereby provide therapeutic benefits for PD patients. …”

5.HT_1A binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

“…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT_1A receptor binding. …”

Variation law of RA and AF in sandstone with different freeze-thaw cycles under a loading rate of 0.05mm/min. by Wenyu Lv (20139458)

HSE suppressed the binding activities of STAT5b to the IGF-1R and STAT3 to the VEGF promoter sites. by Jin Hee Park (153335)

“…Data represent means of at least three separate experiments. Asterisks indicate a statistically significant decrease by t-test (***p<0.001) in the crosstalks of STAT5b/IGF-1R and STAT3/VEGF respectively.…”

Variation law of RA and AF in sandstone with different freeze-thaw cycles under a loading rate of 0.20mm/min. by Wenyu Lv (20139458)

DataSheet_1_Lipopolysaccharide-responsive beige-like anchor is involved in regulating NF-κB activation in B cells.pdf by Daniela Pérez-Pérez (18861310)

“…The NF-κB pathway exhibited a basal activation status of several components, resulting in increased activation of p50, p65, and IκBα, basal p50 activation was reduced by the Plcγ2 inhibitor U73122. …”

Alpha diversity matrix in the Red Sea basin. by Rodrigo Villalobos (4566694)

The difference in the aggregation-independent amyloid removal rate between NC participants and AD patients translates into a much greater relative difference in intratissue amyloid... by Dmitry V. Zaretsky (14034897)

Determination of SARS-CoV 3CL^pro proteolytic rate using the protein substrate by FRET assay. by Chi-Pang Chuck (198242)

Trichostatin A, an epigenetic modifier, mitigates radiation-induced androphysiological anomalies and metabolite changes in mice as evident from NMR-based metabolomics by Teena Haritwal (5847362)

Loss of spermatogonia and wide-spread DNA methylation defects in newborn male mice deficient in DNMT3L-5 by Sophie La Salle (74593)

“…The methylation level of a given locus was compared to the regional GC content of 50kb of flanking sequence; the GC content of a region was characterized as being "low" or "high" if it was, respectively, below or above the average GC content of the analyzed chromosome. …”

Sustained Intensive treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in persons with type 1 diabetes treated with MDI by Marcus Lind (267226)

“…Persons completing the trial (n=141) were invited to participate in the current SILVER extension study in which 107 patients continued CGM treatment over 1 year along with the support of a diabetes nurse every 3 months. <br> <br> </p> <p>Results: The primary endpoint, change in HbA1c over 1.0-1.5 years CGM use compared with previous self-monitoring of blood glucose (SMBG) during GOLD, showed a decrease in HbA1c of 0.35% (95% CI 0.19-0.50), p<0.001. …”

Relationship of mtDNA-CN with disease duration. by Materah Salem Alwehaidah (12054816)